These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 20610012

  • 1. Current use of pimobendan in canine patients with heart disease.
    Boswood A.
    Vet Clin North Am Small Anim Pract; 2010 Jul; 40(4):571-80. PubMed ID: 20610012
    [Abstract] [Full Text] [Related]

  • 2. Pimobendan and its use in treating canine congestive heart failure.
    Bowles D, Fry D.
    Compend Contin Educ Vet; 2011 Nov; 33(11):E1. PubMed ID: 22101450
    [Abstract] [Full Text] [Related]

  • 3. Effect of pimobendan on case fatality rate in Doberman Pinschers with congestive heart failure caused by dilated cardiomyopathy.
    O'Grady MR, Minors SL, O'Sullivan ML, Horne R.
    J Vet Intern Med; 2008 Nov; 22(4):897-904. PubMed ID: 18537880
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of pimobendan in dogs with cardiomegaly caused by preclinical mitral valve disease.
    Boswood A, Smith S, Patteson M.
    Vet Rec; 2011 Feb 26; 168(8):222. PubMed ID: 21493561
    [No Abstract] [Full Text] [Related]

  • 5. Pimobendan in heart failure therapy--a silver bullet?
    Gordon SG, Miller MW, Saunders AB.
    J Am Anim Hosp Assoc; 2006 Feb 26; 42(2):90-3. PubMed ID: 16527909
    [Abstract] [Full Text] [Related]

  • 6. Canine dilated cardiomyopathy: a retrospective study of prognostic findings in 367 clinical cases.
    Martin MW, Stafford Johnson MJ, Strehlau G, King JN.
    J Small Anim Pract; 2010 Aug 26; 51(8):428-36. PubMed ID: 20670255
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Canine heart disease: progress and promise.
    Oyama MA.
    J Small Anim Pract; 2008 Nov 26; 49(11):549-50. PubMed ID: 19006487
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Investigation of pimobendan versus benazepril in canine myxomatous valvular disease.
    Boswood A, McEwan JD, French A, Little C, Swift S, Smith S, Patteson M.
    Vet Rec; 2003 Oct 04; 153(14):439-40. PubMed ID: 14582738
    [No Abstract] [Full Text] [Related]

  • 12. Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group.
    Ettinger SJ, Benitz AM, Ericsson GF, Cifelli S, Jernigan AD, Longhofer SL, Trimboli W, Hanson PD.
    J Am Vet Med Assoc; 1998 Dec 01; 213(11):1573-7. PubMed ID: 9838955
    [Abstract] [Full Text] [Related]

  • 13. Effect of pimobendan on the incidence of arrhythmias in small breed dogs with myxomatous mitral valve degeneration.
    Lake-Bakaar GA, Singh MK, Kass PH, Griffiths LG.
    J Vet Cardiol; 2015 Jun 01; 17(2):120-8. PubMed ID: 26007710
    [Abstract] [Full Text] [Related]

  • 14. A double-blind, randomized, placebo-controlled study of pimobendan in dogs with dilated cardiomyopathy.
    Fuentes VL, Corcoran B, French A, Schober KE, Kleemann R, Justus C.
    J Vet Intern Med; 2002 Jun 01; 16(3):255-61. PubMed ID: 12041654
    [Abstract] [Full Text] [Related]

  • 15. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study.
    Häggström J, Boswood A, O'Grady M, Jöns O, Smith S, Swift S, Borgarelli M, Gavaghan B, Kresken JG, Patteson M, Ablad B, Bussadori CM, Glaus T, Kovacević A, Rapp M, Santilli RA, Tidholm A, Eriksson A, Belanger MC, Deinert M, Little CJ, Kvart C, French A, Rønn-Landbo M, Wess G, Eggertsdottir AV, O'Sullivan ML, Schneider M, Lombard CW, Dukes-McEwan J, Willis R, Louvet A, DiFruscia R.
    J Vet Intern Med; 2008 Jun 01; 22(5):1124-35. PubMed ID: 18638016
    [Abstract] [Full Text] [Related]

  • 16. Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Preclinical Myxomatous Mitral Valve Disease Receiving Pimobendan or Placebo: The EPIC Study.
    Boswood A, Gordon SG, Häggström J, Wess G, Stepien RL, Oyama MA, Keene BW, Bonagura J, MacDonald KA, Patteson M, Smith S, Fox PR, Sanderson K, Woolley R, Szatmári V, Menaut P, Church WM, O'Sullivan ML, Jaudon JP, Kresken JG, Rush J, Barrett KA, Rosenthal SL, Saunders AB, Ljungvall I, Deinert M, Bomassi E, Estrada AH, Fernandez Del Palacio MJ, Moise NS, Abbott JA, Fujii Y, Spier A, Luethy MW, Santilli RA, Uechi M, Tidholm A, Schummer C, Watson P.
    J Vet Intern Med; 2018 Jan 01; 32(1):72-85. PubMed ID: 29214723
    [Abstract] [Full Text] [Related]

  • 17. Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study-A Randomized Clinical Trial.
    Boswood A, Häggström J, Gordon SG, Wess G, Stepien RL, Oyama MA, Keene BW, Bonagura J, MacDonald KA, Patteson M, Smith S, Fox PR, Sanderson K, Woolley R, Szatmári V, Menaut P, Church WM, O'Sullivan ML, Jaudon JP, Kresken JG, Rush J, Barrett KA, Rosenthal SL, Saunders AB, Ljungvall I, Deinert M, Bomassi E, Estrada AH, Fernandez Del Palacio MJ, Moise NS, Abbott JA, Fujii Y, Spier A, Luethy MW, Santilli RA, Uechi M, Tidholm A, Watson P.
    J Vet Intern Med; 2016 Nov 01; 30(6):1765-1779. PubMed ID: 27678080
    [Abstract] [Full Text] [Related]

  • 18. A review of the pharmacology and clinical uses of pimobendan.
    Boyle KL, Leech E.
    J Vet Emerg Crit Care (San Antonio); 2012 Aug 01; 22(4):398-408. PubMed ID: 22928748
    [Abstract] [Full Text] [Related]

  • 19. Preclinical dilated cardiomyopathy in the dobermann.
    Summerfield N, Dukes-McEwan J, Swift S, Patteson M, Wotton P, Martin M, Johnson M, Boswood A, Fuentes VL, French A, Culshaw G, Little C, Smith P, Smith S, Willis R.
    Vet Rec; 2006 May 27; 158(21):742-3. PubMed ID: 16731709
    [No Abstract] [Full Text] [Related]

  • 20. Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving pimobendan or benazepril: the QUEST study.
    Häggström J, Boswood A, O'Grady M, Jöns O, Smith S, Swift S, Borgarelli M, Gavaghan B, Kresken JG, Patteson M, Åblad B, Bussadori CM, Glaus T, Kovačević A, Rapp M, Santilli RA, Tidholm A, Eriksson A, Belanger MC, Deinert M, Little CJ, Kvart C, French A, Rønn-Landbo M, Wess G, Eggertsdottir A, Lynne O'Sullivan M, Schneider M, Lombard CW, Dukes-McEwan J, Willis R, Louvet A, DiFruscia R.
    J Vet Intern Med; 2013 May 27; 27(6):1441-51. PubMed ID: 24010489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.